While the disbalance between CtsB and StfA may represent a reliable disease progression marker, this phenomenon should be explored in the specific context of tissue and cancer type, and to our knowledge, no previous studies have investigated CtsB and StfA in RCC. Here, CTSB is linked to renal cell carcinoma.